Endocrine Abstracts

Objectives: Correction of 131I dose for thyroid gland size is one of the methods used to determine radioactive iodine (RAI) activity for patients with Graves’ disease (GD), but the predictive factors for its clinical outcome are still unclear. This study aimed to investigate which factors influence its success in a real-world cohort.Methods: Observational and retrospective study of RAI treatments in a terciary referral center in Almada, Portugal, ca...

Objective: To evaluate the success of administration of 131Iodine adjusted for thyroid gland size in the treatment of hyperthyroidism in Graves’ disease.Methods: All patients with Gravés hyperthyroidism who underwent therapeutic administration of 131I in a referral center in Portugal, from 2014 to 2022 were selected. Values of estimated thyroid gland size, administrated doses of 131I and 24h radioactive iodine u...